![Pharmaceutical composition containing 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione or a pharmaceutically acceptable salt thereof](/docs/US/2020-06-02/US10668073B2/abs.jpg.600x600.jpg)
- Patent Title: Pharmaceutical composition containing 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione or a pharmaceutically acceptable salt thereof
-
Application No.: US15767131Application Date: 2016-10-07
-
Publication No.: US10668073B2Publication Date: 2020-06-02
- Inventor: Andreas Krekeler
- Applicant: HEXAL AG
- Applicant Address: DE Holzkirchen
- Assignee: HEXAL AG
- Current Assignee: HEXAL AG
- Current Assignee Address: DE Holzkirchen
- Agency: Hershkovitz & Associates, PLLC
- Agent Abe Hershkovtiz
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@50675217
- International Application: PCT/EP2016/073952 WO 20161007
- International Announcement: WO2017/060398 WO 20170413
- Main IPC: A61K31/522
- IPC: A61K31/522 ; A61K9/20 ; A61K9/16 ; A61K9/28
![Pharmaceutical composition containing 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione or a pharmaceutically acceptable salt thereof](/abs-image/US/2020/06/02/US10668073B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to a pharmaceutical composition comprising linagliptin or a pharmaceutically acceptable salt thereof as active ingredient, wherein the pharmaceutical composition does not comprise a binder and wherein the pharmaceutical composition is obtained by direct compression.
Public/Granted literature
Information query
IPC分类:
